9 big questions about Pelosi’s drug pricing bill

House Speaker Nancy Pelosi’s plan to lower drug prices has finally gone live, after months of rumors, speculation, leaked drafts, and back-and-forth between House progressives and the speaker’s policy advisers. But there are still big questions looming. Our D.C. correspondents have compiled — and answered — nine of them. A few to get you started: Will progressives support the plan, after the dust settles? How about moderates? Or even the White House itself? What drugs are we talking about, anyway? There are needles Pelosi’s plan must thread and international pricing indexes that must be calculated. Let Nicholas Florko and Lev Facher share what they’ve learned.

Want more Washington intel? Sign up for our free weekly newsletter D.C. Diagnosis.